SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-024980
Filing Date
2022-11-14
Accepted
2022-11-14 16:05:17
Documents
15
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eldn-20221114.htm   iXBRL 8-K 55772
2 COURTESY COPY OF ELDN_2022.11.14_8-K_NEW eldn-eldn_2022.11.14_8-k_new.pdf 8-K 363114
3 EX-99.1 eldn-ex99_1.htm EX-99.1 255928
4 GRAPHIC img20068692_0.jpg GRAPHIC 7613
  Complete submission text file 0000950170-22-024980.txt   950960

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eldn-20221114_lab.xml EX-101.LAB 13360
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eldn-20221114_pre.xml EX-101.PRE 9839
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eldn-20221114.xsd EX-101.SCH 2463
9 EXTRACTED XBRL INSTANCE DOCUMENT eldn-20221114_htm.xml XML 4703
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 221385062
SIC: 2834 Pharmaceutical Preparations